Concourse Financial Group Securities, Inc. Amarin Corp Plcuk Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 8,000 shares of AMRN stock, worth $4,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$4,800
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMRN
# of Institutions
187Shares Held
77.1MCall Options Held
247KPut Options Held
121K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$14.9 Million2.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.2MShares$7.29 Million0.65% of portfolio
-
Dg Capital Management, LLC New York, NY5.12MShares$3.07 Million1.36% of portfolio
-
Eversept Partners, LP New York, NY4.31MShares$2.59 Million0.22% of portfolio
-
Two Sigma Investments, LP New York, NY3.04MShares$1.82 Million0.01% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $242M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...